Document is current
Any future updates will be listed below
-
Authors
Becker, Jürgen C. https://orcid.org/0000-0001-9183-653X
Stang, Andreas https://orcid.org/0000-0001-6363-9061
Schrama, David https://orcid.org/0000-0002-6931-8194
Ugurel, Selma https://orcid.org/0000-0002-9384-6704
-
Funding
Funding for this research was provided by:
BMBF - DKTK (ED03)
Universitätsklinikum Essen
- License Information
-
More Information
Article History
Accepted: 21 March 2024
First Online: 22 April 2024
Declarations
:
: Open Access funding enabled and organized by Projekt DEAL. Funding was provided by BMBF - DKTK (ED03).
: JCB is receiving speaker’s bureau honoraria from Amgen, Pfizer, and Sanofi and is a paid consultant/advisory board member/data and safety monitoring board (DSMB) member for Almirall, Boehringer Ingelheim, ICON, Merck, Pfizer, and Sanofi. His group receives research grants from Merck, HTG, IQVIA, and Alcedis. SU declares research support from Bristol Myers Squibb and Merck; speaker and advisory board honoraria from Bristol Myers Squibb, Merck Sharp & Dohme, Merck Serono, and Novartis; and meeting and travel support from Almirall, Bristol-Myers Squibb, IGEA Clinical Biophysics, Merck Sharp & Dohme, Novartis, Pierre Fabre, and Sun Pharma. AS and DS declare that they have no conflicts of interest that might be relevant to the contents of this manuscript.
: Not applicable.
: No datasets were generated or analyzed for this review article.
: Not
: All authors were involved in the literature research, writing the initial draft and the revision process. All authors read and approved the final manuscript.
